Ann: Pfizer raises scheme consideration to A$0.208 per share, page-60

IMO with the small steps they try to transmit the feeling that it was the last rise. Its like David vs Goliath. What is, lets say a billion? Pfizer has already overtaken RAP. IMO I personally think David has good chances to anger Goliath. We have a weak sh register. But on the other hand a looooot of retail holders. You awaited to own a company who is a lifechanging opportunity? Here we are. If not RAP which other company is closer? As I say, I very Welcome Pfizer. But as a Cornerstone shareholder or Partner. Lets do it togheter. Overtake Raps as a subsidiary company.

all IMO and perception. At asx my strategy is keep till the end. ;-) bio dollar company, TO or chapter 11. : - ) absolutely no investment advice. Just my opinion.